I. Pérez

Safety of triflusal (antiplatelet drug) in patients with aspirin‐exacerbated respiratory diseases

J. Fraj, A. Valero, C. Picado, 2007, Allergy.

Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.

E. Arnáiz, J. Conde, E. Martí-Guadaño, 2005, Journal of investigational allergology & clinical immunology.

A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.

I. Izquierdo, I. Pérez, F. Saint-Martin, 2004, Journal of investigational allergology & clinical immunology.

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19

A. Rodríguez-Molinero, C. Gálvez-Barrón, C. Pérez-López, 2020, One Health.

Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre study

E. Arnáiz, A. Giménez-Arnau, S. Ianoși, 2007, Allergy.

Effectiveness, safety and cost of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world data analysis

I. Pérez, J. L. Marco, M. Faus, 2018, Clinical and Translational Oncology.

Effectiveness and safety of Stevia rebaudiana dried leaves as an adjuvant in the short-term treatment of type 2 diabetes : A randomized , controlled , cross-over and double-blinded trial

I. Pérez, Genís Carrasco, M. Rodríguez, 2015 .